Clinical Trial Update: Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15% [NA]

View source ↗

Summary

A clinical trial update evaluating the performance and safety of hyaluronic acid eye drops at 0.30% and 0.15% for dry eye syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Hyaluronic Acid Eye Drops 0.15% (sodium hyaluronate)
• Hyaluronic Acid Eye Drops 0.30% (sodium hyaluronate)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Dry Eye Syndrome (DES) | NA | Status: UNKNOWN